COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome
04/10/2018
Press release - No. 21/2018 Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome The Phase 3 registration trial has enrolled the first short bowel syndrome ( [...]
FIT Biotech Oy: FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus
04/10/2018
FIT Biotech Oy Company release 04.10.2018 at 11:00 AM EET FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus FIT Biotech Oy ("Company", FITBIO: FN Finland) has filed [...]
Recording of the Second Quarter 2018 Investor Conference Webinar
04/10/2018
On October 3 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the Advisor to the Board of AS „Olainfarm” Salvis Lapiņš analyzed the financial results of second quarter 2018 and [...]
Ambu A/S: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018
04/10/2018
One year into the strategy period Ambu is ready to launch four new products and upgrade the long-term financial targets for 2020. Contact Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com [...]
Xbrane Biopharma announces results of in-vivo study showing equivalent tolerability and pharmacokinetic profile of Xlucane compared to Lucentis®
04/10/2018
Press release 2018-10-04 In an in-vivo study involving 16 New Zeeland White rabbits Xlucane (ranibizumab (Lucentis ® ) biosimilar) demonstrated equivalent tolerability and pharmacokinetic profile in the serum and in the [...]
Rule 2.9 Announcement
04/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 October 2018 [...]
Saniona Completes Planned Patient Recruitment for Second Part of Phase 2a Study for Tesomet in Prader-Willi Syndrome
04/10/2018
PRESS RELEASE October 4, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has completed the planned recruitment of adolescents for the second part of its Phase 2a study of [...]
Sandoz Healthcare Access Challenge (HACk) returns, seeking digital solutions to local healthcare access challenges
04/10/2018
Despite major advances in modern medicine, universal access to healthcare remains the largest unmet medical need Building on the inaugural Sandoz HACk, this year's competition expands to seek broader digital solutions [...]
Guardant Health Announces Pricing of Initial Public Offering
04/10/2018
REDWOOD CITY, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH) today announced the pricing of its initial public offering of 12,500,000 shares of common stock at a public offering price of $19 [...]
Amedisys Extends Employment Agreement with CEO Paul Kusserow
03/10/2018
On Heels of Company Turnaround, Will Stay On For Three More Years BATON ROUGE, La., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), America’s leading independent home health, hospice and personal care [...]
Spring Bank Announces Inarigivir Data Presentations at AASLD Conference
03/10/2018
HOPKINTON, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis
03/10/2018
VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC Labs ) (TSX-V: ICC) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia [...]
KemPharm to Host KOL Investor Event Focused on the ADHD Treatment Landscape
03/10/2018
Event to be Webcast Live on Thursday, October 11, 2018, at 8:30 a.m. ET CORALVILLE, Iowa, Oct. 03, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and [...]
BioPorto receives communication from FDA regarding The NGAL Test™
03/10/2018
October 3, 2018 Announcement no. 17 BioPorto receives communication from FDA regarding The NGAL Test™ BioPorto A/S (“BioPorto”) announces today that the company has received communication from the U.S. Food and Drug [...]
Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses
03/10/2018
SAN DIEGO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that presentations highlighting the design of the ongoing pivotal Phase 3 FORT Study of fosmetpantotenate for the treatment of [...]
Acasti Pharma Announces Public Equity Offering
03/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”) is pleased [...]
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
03/10/2018
MONTRÉAL, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
Corvus Pharmaceuticals Announces Publication of Preclinical Results Highlighting Antitumor Activity of CPI-444 in Multiple Tumor Models both as Monotherapy and in Combination Studies
03/10/2018
As Combination, CPI-444 Showed Elimination of Tumors in 90% of Treated Mice and Restoration of Immune Response in Mice with Tumors Resistant to Therapy with anti-PD-1 and anti-CTLA-4 BURLINGAME, Calif., Oct. 03, 2018 ( [...]
Paratek Pharmaceuticals, Inc. to Host Investor Day on October 23, 2018
03/10/2018
BOSTON, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Pages